ArticleJournal of surgical case reports2019
Primary squamous cell carcinoma of the breast: a case report and review of the literature.
Article in Journal of surgical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Article
- Palmar squamous cell carcinoma with lymph node involvement: a case report highlighting diagnostic challenges.Annals of medicine and surgery (2012) · 2026Article
- A Case of Squamous Cell Carcinoma Arising From an Intraductal Papilloma of the Breast.Clinical case reports · 2025Article
- Role of NOX1 and NOX5 in protein kinase C/reactive oxygen species‑mediated MMP‑9 activation and invasion in MCF‑7 breast cancer cells.Molecular medicine reports · 2024Article
- Primary Squamous Carcinoma: A Description of a Rare Histological Type of Breast Cancer.Cureus · 2024Article
- Invasive breast carcinoma with ipsilateral axillary squamous carcinoma of unknown primary: A case report.International journal of surgery case reports · 2024Article
- Primary breast squamous cell carcinoma: A case report at a tertiary hospital in Northern Tanzania.Clinical case reports · 2023Article
- Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report.Frontiers in pharmacology · 2023Article
- Significant efficacy of paclitaxel plus carboplatin (TP) as a neoadjuvant regimen for metaplastic squamous cell carcinoma of the breast: a rare case report and literature review.Translational cancer research · 2022Article
- Primary squamous cell carcinoma of the breast: A case report and review of the literature.Frontiers in oncology · 2022Article
- HPV-positive cervical squamous cell carcinoma metastasis to the breast, mimicking primary tumor.Breast disease · 2022Article
- Ultrastructural analysis of breast cancer patient-derived organoids.Cancer cell international · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary squamous cell carcinoma of the breast is a rare tumor. The prognosis is poor, and hence there is a clinical trend to offer multi-modal treatment options of surgery, chemotherapy, and radiation therapy. There is no consensus on treatment options due to the paucity of available data. We are reporting the case of a 68-year-old lady who presented with a right breast mass. Upon core biopsy and further workup, she was noted to have primary squamous cell carcinoma of the breast. She was successfully treated with surgical therapy alone without disease recurrence at 36 months. Primary squamous cell carcinoma of the breast can be treated successfully with surgical therapy alone. The role of adjuvant chemotherapy, radiation therapy, and anti-estrogen therapy should be questioned as these modalities can lead to significant treatment-related morbidities and might not be contributing to disease-free interval or overall survival from this unusual tumor subtype.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.